Sight Sciences , Inc. (NASDAQ:) lately noticed its Government Vice President of Analysis & Improvement, Manohar Ok. Raheja, make a major buy of the corporate’s widespread inventory. Based on a submitting with the Securities and Alternate Fee, Raheja acquired 3,376 shares on December 3, 2024, at a value of $3.89 per share. This transaction quantities to a complete worth of $13,132. Following this buy, Raheja’s complete possession within the firm stands at 106,000 shares. InvestingPro information reveals the corporate maintains a powerful stability sheet with additional cash than debt, although inventory value actions stay fairly unstable. For deeper insights into insider buying and selling patterns and eight further ProTips, take into account exploring the great Professional Analysis Report out there on InvestingPro.
In different latest information, Sight Sciences, Inc. reported a minor year-over-year income enhance in its third-quarter earnings name regardless of the outcomes falling wanting expectations. The corporate’s third-quarter income rose 1% year-over-year to $20.2 million, with surgical glaucoma income at $18.6 million. Nonetheless, it witnessed a sequential lower of 8% in surgical glaucoma income and a lower in OMNI machine utilization attributable to competitors and LCD course of uncertainty.
Regardless of these setbacks, Sight Sciences stays optimistic about progress within the surgical glaucoma and dry eye segments in 2025. The corporate is contesting the ultimate 2025 Medicare fee rule, which didn’t grant device-intensive standing to OMNI procedures, and is concentrated on enhancing its gross sales efficiency and strategic positioning.
Latest developments embody the appointment of Dr. MK Raheja as Government Vice President of Analysis and Improvement to advance their surgical glaucoma pipeline. Moreover, Sight Sciences has carried out over 200,000 OMNI and 60,000 TearCare procedures, demonstrating the corporate’s ongoing dedication to enhancing affected person care and increasing market entry.
This text was generated with the help of AI and reviewed by an editor. For extra info see our T&C.
